Detalhe da pesquisa
1.
Pharmacokinetics, Safety, and Tolerability of a Single 5-Day Treatment of Tirbanibulin Ointment 1% in 100 cm2 : A Phase 1 Maximal-Use Trial in Patients with Actinic Keratosis.
Clin Pharmacol Drug Dev
; 13(2): 208-218, 2024 02.
Artigo
Inglês
| MEDLINE | ID: mdl-38185925
2.
Mass balance and metabolism of aclidinium bromide following intravenous administration of [¹4C]-aclidinium bromide in healthy subjects.
Biopharm Drug Dispos
; 33(1): 39-45, 2012 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-22275272
3.
Absolute bioavailability, pharmacokinetics, and urinary excretion of the novel antimigraine agent almotriptan in healthy male volunteers.
J Clin Pharmacol
; 42(12): 1303-10, 2002 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-12463724
4.
Safety and tolerability of aclidinium administered intravenously and absolute bioavailability of inhaled aclidinium in healthy male participants.
J Clin Pharmacol
; 52(6): 819-27, 2012 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-21628603
5.
Pharmacokinetics and safety of aclidinium bromide, a muscarinic antagonist, in adults with normal or impaired renal function: A phase I, open-label, single-dose clinical trial.
Clin Ther
; 32(10): 1798-812, 2010 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-21194604
6.
Safety and pharmacokinetics of multiple doses of aclidinium bromide, a novel long-acting muscarinic antagonist for the treatment of chronic obstructive pulmonary disease, in healthy participants.
J Clin Pharmacol
; 49(10): 1239-46, 2009 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-19592595
7.
Incurred sample reproducibility: views and recommendations by the European Bioanalysis Forum.
Bioanalysis
; 1(6): 1049-56, 2009 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-21083073
8.
Identification of the human liver enzymes involved in the metabolism of the antimigraine agent almotriptan.
Drug Metab Dispos
; 31(4): 404-11, 2003 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-12642466
9.
Almotriptan, a new anti-migraine agent: a review.
CNS Drug Rev
; 8(3): 217-34, 2002.
Artigo
Inglês
| MEDLINE | ID: mdl-12353056